Black Diamond Therapeutics (BDTX) Earnings Date & Reports

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BDTX is expected to report earnings to fall 117.11% to 4 cents per share on May 07

Black Diamond Therapeutics BDTX Stock Earnings Reports

Q1'25

Est.

$0.05

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.09

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.08

The last earnings report on March 06 showed earnings per share of -28 cents, beating the estimate of -34 cents. With 1.72M shares outstanding, the current market capitalization sits at 87.54M.

View a ticker or compare two or three

Compare

BDTX